ONFO vs HIMS vs DCOM vs ITRM vs CODA

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus 13. 0% for Dime Community Bancshares, Inc. (DCOM). Dime Community Bancshares, Inc. (DCOM) offers the better valuation at 15. 7x trailing P/E (10. 7x forward), making it the more compelling value choice. Analysts rate Coda Octopus Group, Inc. (CODA) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Dime Community Bancshares, Inc.

(DCOM) is the cheapest at 15. 7x versus Hims & Hers Health, Inc. at 50. 3x. On forward P/E, Dime Community Bancshares, Inc. is actually cheaper at 10. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Dime Community Bancshares, Inc. wins at 1. 68x versus Coda Octopus Group, Inc. 's 5. 24x — a reasonable growth-adjusted valuation.

Over the past 5 years, Hims & Hers Health, Inc.

(HIMS) delivered a total return of +137. 6%, compared to -99. 8% for Iterum Therapeutics plc (ITRM). Over 10 years, the gap is even starker: CODA returned +844. 4% versus ITRM's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Coda Octopus Group, Inc.

(CODA) is the lower-risk stock at 1. 00β versus Hims & Hers Health, Inc. 's 2. 40β — meaning HIMS is approximately 140% more volatile than CODA relative to the S&P 500. On balance sheet safety, Coda Octopus Group, Inc. (CODA) carries a lower debt/equity ratio of 1% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus 13. 0% for Dime Community Bancshares, Inc. (DCOM). On earnings-per-share growth, the picture is similar: Dime Community Bancshares, Inc. grew EPS 330. 9% year-over-year, compared to -3. 8% for Hims & Hers Health, Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Coda Octopus Group, Inc.

(CODA) is the more profitable company, earning 15. 5% net margin versus -69. 1% for Iterum Therapeutics plc — meaning it keeps 15. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DCOM leads at 21. 5% versus -52. 0% for ITRM. At the gross margin level — before operating expenses — CODA leads at 66. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Dime Community Bancshares, Inc. (DCOM) is the more undervalued stock at a PEG of 1. 68x versus Coda Octopus Group, Inc. 's 5. 24x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Dime Community Bancshares, Inc. (DCOM) trades at 10. 7x forward P/E versus 51. 5x for Hims & Hers Health, Inc. — 40. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CODA: 17. 6% to $14. 00.

In this comparison, ONFO (5.

6% yield), DCOM (2. 7% yield) pay a dividend. HIMS, ITRM, CODA do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Coda Octopus Group, Inc.

(CODA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 00), +844. 4% 10Y return). Hims & Hers Health, Inc. (HIMS) carries a higher beta of 2. 40 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CODA: +844. 4%, HIMS: +161. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ONFO (Communication Services) and HIMS (Healthcare) and DCOM (Financial Services) and ITRM (Healthcare) and CODA (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ONFO is a small-cap high-growth stock; HIMS is a small-cap high-growth stock; DCOM is a small-cap deep-value stock; ITRM is a small-cap quality compounder stock; CODA is a small-cap high-growth stock. ONFO, DCOM pay a dividend while HIMS, ITRM, CODA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.